NHS Guidance on GLP-1 Agonist Treatment Options NICE guidance provides the framework for GLP-1 agonist prescribing within the NHS, balancing clinical effectiveness with cost-effectiveness considerations
Occasionally, FSAs may ask for the Letter to confirm the eligibility of your purchase
One common diet question among people taking these drugs, which include Ozempic or Mounjaro for type 2 diabetes and Wegovy or Zepbound for obesity, is: Can I drink on a GLP-1
When we look at an aging face, collagen loss is only one piece of the puzzle
Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes: a systematic review and meta-analysis
They were all large-scale trials involving 3,000 to 18,000 patients who were either at high risk of or having established ASCVD, with trial durations ranging from 15 to 60 months